Skip to content

Biogen BIIB Debt-to-assets

Debt-to-assets at other companies

Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
0.1×0.0×
Eli Lilly logo
Eli LillyLLY
0.4×-0.1×
Royalty Pharma logo
Royalty PharmaRPRX
0.5×0.0×
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
0.5×0.0×
Amgen logo
AmgenAMGN
0.6×0.0×
Incyte logo
IncyteINCY
0.0×

Other financials

Income statement

See full
Revenue$2.5B+1.9%
Gross profit$1.8B+0.8%
Net income$319.5M+32.9%
EPS (diluted)$2.15+31.1%

Balance sheet

See full
Cash & equivalents$3.4B+30.2%
Total debt$6.6B+34.7%
Total equity$18.7B+9.9%
Total assets$29.5B+5.2%

Cash flow

See full
Operating cash flow$645.5M+149%
CapEx$51.2M+38.0%
Free cash flow$594.3M+167%

Valuation

See full
Market cap$29.02B+34.3%
Enterprise value$32.2B+34.9%
P/E20.4×+5.8×
P/S2.9×+0.7×

Profitability

See full
Gross margin75.5%-0.1pp
Operating margin22.9%
Net margin14.3%-0.8pp

Returns & leverage

See full
Return on equity8%-1.2pp
Debt / equity0.4×+0.1×
Current ratio3.1×+1.6×

Where this comes from

Calculated from Biogen’s reported figures.

Based on the most recent quarter.

The official record: Biogen’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biogen's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biogen's debt-to-assets?
Biogen (BIIB) reported debt-to-assets of 0.2× in Q1 2026.
How has Biogen's debt-to-assets changed year-over-year?
Biogen's debt-to-assets increased by 28.1% year-over-year, from 0.2× to 0.2×.
What is the long-term trend for Biogen's debt-to-assets?
Over 4 years (2021 to 2025), Biogen's debt-to-assets has grown at a -8.7% compound annual growth rate (CAGR), from 1.2× to 0.9×.
What does debt-to-assets mean?
What fraction of everything the company owns is funded by debt.
How do you interpret debt-to-assets?
A lower ratio indicates a more conservatively financed balance sheet. Rising debt-to-assets over time signals increasing financial risk.
How does debt-to-assets compare across companies?
Comparable within an industry; bounded between 0 and 1 for most non-financials, which makes cross-company reads cleaner than debt-to-equity.